In Silico Study of Different Thrombolytic Agents for Fibrinolysis in Acute Ischemic Stroke
Sign Up to like & getrecommendations! Published in 2023 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics15030797
Abstract: Alteplase is the only FDA-approved drug for thrombolysis in acute ischemic stroke (AIS). Meanwhile, several thrombolytic drugs are deemed to be promising candidates to substitute alteplase. This paper evaluates the efficacy and safety of urokinase,… read more here.
Keywords: different thrombolytic; silico study; acute ischemic; study different ... See more keywords